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Abstract 
The study aims to highlight the usefulness of micro accounting approach as tool of clinical governance starting 
from the data provided by the computerization of services and medical records. The case study takes into account 
data collected over two years between three departments of the same hospital for the management of patients 
with acute gastric ulcer with bleeding and variations and acute duodenal ulcer with bleeding and variations. All 
statistical analyses were performed using STATA V.14.2 (Stata Corp, College Station, Texas, USA, 2013) and p 
value <0.05 was considered significant for all analyses. The analysis of economic and comorbidity data provides 
useful insights to guide the choice of the treatment pathway between departments, and provides useful 
indications for the redefinition of guidelines towards a rationalization of healthcare expenditure. 
Keywords: Micro-costing approach, health decision-making, Healthcare, performance management system, 
peptic ulcer bleending 
1. Introduction 
The growing attention to the financial balance of the Italian Healthcare System (IHS) has led, in recent years, to 
a reduction in the deficit and to an effective containment of the average annual growth rate of the overall health 
care per capita expenditure, which went from 1.7% in the period 2000-2010 to 0.7% per year between 2010 and 
2016, among the lowest in the European Union (OASI, 2017). Specifically, a series of cost-containment 
measures which were implemented in the aftermath of the 2008 economic crisis, led to a reduction in public 
funding for health. Indeed, co-payments for medicines and for inappropriate use of hospital emergency services 
were implemented in most regions following the introduction of the Deficit Reduction Plans (EU Companion 
Report, 2017). According to the OASI report, public sources still cover 95% of hospital expenditure, but only 60% 
of expenditure on outpatient services and 65% of long-term care costs in residential facilities, which are defined 
as being the Achilles heel of the Italian Health System (OASI, 2017). While the IHS has been in economic 
equilibrium for some years, the report highlights: i) a gap between health resources and the needs of 
citizens/patients, characterised by a demographic aging, combined with the increase in life expectancy, which 
will further increase demand for care and ii) an alarming and permanent gap between the North and South of the 
country in terms of population health. In this background, the Italian healthcare spending, that is still much lower 
than that of other European countries, can only be reduced through the optimization of resources, organizational 
and technological innovation, citizen/patient empowerment and the definition of new skills for health 
professionals. The sustainability of the system over time, however, depends above all on the ways in which 
expenditure restraints have been obtained, making it necessary to analyse whether the focus of health policies 
and managerial choices has exclusively been, or mainly addressed to the linear reduction of individual 
consumption health system inputs (personnel costs, purchase of goods and services) or whether the focus was on 
the search for efficiency and effectiveness, encouraging optimal use of inputs in relation to outputs and outcomes 
of health services provided (Ballantine et al., 1998; Hill, 2000; Vannucci et al., 2001; Cinquini et al., 2007; Nuti 
et al., 2011; Tieghi et al., 2016; Murante et al., 2017). As a matter of fact, if overall the INH service is financially 
balanced, this does not necessarily correspond to the ability to respond to the needs of citizens and to provide 
services in an efficient and appropriate manner. Healthcare decisions to improve quality of patients’ care require 
having good knowledge of the health condition (professional evidence), taking into account patient-specific 
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aspects of medical care (contextual care), and contriving policy strategies to guarantee equity and appropriate 
use of resources, including avoiding waste (policy evidence) (De Maeseneer, 2017). 
The research is inspired by the need of healthcare entities to rationalize the resources available (Leotta and 
Ruggeri, 2012), giving health professionals awareness of the costs related to alternative choices of intervention 
and treatment of the same pathology (Russo, 2011; Nuti et al., 2010), engaging them to optimize the choices and 
to improve the organizational and operational processes that lead to the expected outcomes (Smaldone and 
Vainieri, 2016). Many previous studies have already analyzed in depth the cost accounting systems in alternative 
care pathways, through the use of activity based and micro-costing approaches (Chan & Ching, 1993; Evans et 
al., 1997; Ross, 2004; Pizzini, 2006; Cinquini et al., 2007; Russo, 2011; Goldberg and Kosinski, 2011, Battaglia 
and Pedretti, 2012; Perazzo et al., 2017; Rejeb et al., 2017). The present study is part of this line, assuming a 
costing perspective aimed at providing information for the choices and assessments addressed to the hospital 
management, in particular, focusing on the correlation between organizational aspects and the analysis of the 
specific resources consumed in each alternative. In practice, the analysis is conducted in depth on each 
individual patient, through the close collaboration between medical researchers and business professionals, 
whose goal and final intent is to verify the appropriateness of the resources used in relation to the treatment 
pathways and the outputs and outcomes obtained.  
The research deals with the analysis of the efficiency of the therapeutic pathway carried out by the patients 
diagnosed with bleeding peptic ulcer at the main Piedmontese hospital “Città della Salute e della Scienza di 
Torino”. The objective of the study is to assess and analyse the costs of the therapeutic process performed on 
each patient, according to the type of hospital ward (gastroenterology, general medicine and emergency 
medicine), in order to: i) determine the cost of each patient, based on the specific therapeutic path realized; ii) 
comparing the cost of alternative therapeutic pathways, based on the observational approach applied in 
agreement with the physicians, with the aim of hypothesising optimal intervention processes and optimization of 
the relative cost-benefit. Moreover, the study aims to determine if there is a statistical correlation between the 
variables that characterise the single cases being analysed (e.g. comorbidity, level of bleeding, method of 
treatment) that would allow the identification of significant variations in average length of stay and hospital costs, 
depending on the hospital ward where the patient is admitted. 
The remainder of the study is structured as follows. In paragraph 2, a brief description of the literature makes it 
possible to understand the relevance and the dimensions analyzed. The paragraph 3 is dedicated to the research 
design, with a description of the methods of data collection and analysis, while in paragraph 4 the results of the 
analysis carried out in a Piedmontese hospital are presented and discussed. Paragraph 5 is dedicated to final 
conclusions and further research development. 
2. Literature Review 
In order to understand the implications related to both the objectives of the paper, the background analysis is as 
follow: a brief description of the pathology under study (2.1), the previous research related to “the 
managerialization” of the healthcare system (2.2) and the cost accounting approach applied in the case study 
(2.3). 
2.1 A Brief Description of the Peptic Ulcer Bleending 
Peptic ulcer bleeding is a disease of considerable interest from, undoubtedly, a medical point of view, as well as 
from an economic and management perspective. Indeed, it is one of the most important reasons why patients turn 
to a gastroenterologist, as well as being one of the most frequent diseases that requires hospital admission (Lin et 
al.; 1996; Gralnek et al, 2008). Peptic ulcer bleeding is the main cause of upper gastro-intestinal bleeding 
(UGIB), a condition which involves between 40 and 50 cases on average per 100,000 inhabitants annually and 
an estimated mortality risk estimated at around 8% of patients with the disease. In patients affected by UGIB 
from a non-variceal source around 80-90% are diagnosed, on the one hand, with duodenal peptic ulcer which 
develops in the upper part of the small intestine (15-35% of cases) and, on the other, with gastric peptic ulcer 
which affects the stomach (10-25% of cases) (Hreinsson et al., 2013a; Hreinsson et al., 2013b). It must be 
pointed out that there may be other causes responsible for UGIB, less common, but not less significant, although 
they are not mentioned here as they are not part of the present study. In light of these characteristics, it is clear 
that the treatment of the disease has a considerable impact on the number of emergency hospital admissions and, 
as a consequence, a high consumption of medical-healthcare and financial resources (Cheung & Lau, 2009; 
Khamaysi & Gralnek, 2013; Cassieri et al., 2016). In medical and economic literature, both national and 
international, fact-finding surveys aimed at demonstrating if there are significant differences in the various 
specialised treatments and care processes for the management of the ulcer and its complications are rare and not 
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sufficiently detailed nor thorough. The most relevant studies are those of Quirk et al. (1997) carried out at the 
Harvard Medical School of Boston and of Pardo et al. (2002) carried out at the University Hospital of the Canary 
Islands in Tenerife. The analysis of Quirk et al. (1997) was conducted to ascertain if the cost of treating patients 
with upper gastro-intestinal bleeding varied on the basis of which hospital specialist care unit the patients were 
admitted to. Pardo et al. (2002) analysed the impact of physician specialty on the costs related to the treatment of 
non-variceal upper gastro-intestinal bleeding. Their studies clearly showed significant differences in response 
time to patient care in the various hospital wards and showed variations in the cost of treating patients in the 
different specialist care units (hospital department), while there were no differences related to risk factors. In 
particular, Pardo’s et al. study identified a positive correlation between the implementation of specific 
evidence-based protocols by gastroenterologists and the reduction in the length of hospital stay and related costs. 
Following this theoretical introduction to the present study, the aim that arises is to analyse the methods of 
treating upper gastro-intestinal bleeding, measuring the economic effects in terms of the costs, through a study 
carried out at the Città della Salute e della Scienza di Torino during the period 2015-2016. The reference sample 
is made up of those patients managed by the Hospital who at the time of their discharge were found to have been 
diagnosed with upper gastro-intestinal bleeding. This medical centre is the biggest at a national and European 
level, with 9,500 employees, 2,311 beds and 181,330 emergency admissions in 2016 (Archives "Discharges and 
Services" - CSI Piedmont, 2016).  
2.2 The Current Relevance of the “Managerialization” of the Healthcare System 
In Italy, the healthcare sector represents one of the most important elements in the economic system with 
reference to: number of employees, variety of services on offer, consumption of resources, impact on growth and 
complexity of production methods. In the public healthcare service, the “managerialization” (Pollit, 1990; 
Newman and Clarke, 1994) of the National Healthcare System (NHS), which started with the Reforms of 
1992-93 and reinforced with Legislative Decree 229/99, has progressively made the introduction of a 
well-structured and multifaceted system to assess healthcare qualitative and quantitative performances (Nuti et 
al., 2010; Del Gesso, 2014; Brescia et al. 2016; Nuti et al., 2016; Vaineri et al., 2017) and it is closely linked to 
the need to guarantee accountability in the public sector as well. Clinical Governance has been one of the 
management tools adopted in healthcare companies to pursue a continuous and progressive improvement in 
healthcare quality (Flynn, 2002; Swage, 2004; Scally & Donaldson, 1998; Whitehead, 1991; WHO 1983). It 
gives two macro responsibilities to healthcare organisations: to continuously improve the quality of their services 
and to maintain high standards of care as well as high patient satisfaction (De Masi al., 2001; Nuti et al., 2017). 
The long-term goal of its implementation is to create an environment which stimulates the best professional 
performance (Quintaliani & Gori, 2002). In more concrete terms, the fulfillment of Clinical Governance involves 
the full recognition of multidimensional performance indicators, which can be grouped into risk-controlled 
medical assistance, results-based efficiency, appropriate professional and organisational quality, 
patient-centredness approach to the planning and delivery of services (Pelissero, 2012) allowing for more 
accessible care and guaranteeing technical and allocative efficiency in the organisational system and in 
healthcare delivery (Fontana, 2005). Today it can be said that, in managerial terms, the level of maturity of 
healthcare entities has improved, with the formal affirmation of planning and control mechanisms, of managerial 
accounting tools and well-structured responsibility maps. However, despite this promising situation, the planning 
and control systems are often based on compliance with the requirements and procedures, rather than on the 
substantial need to lead the management towards multi-dimensional perspectives that include the expectations of 
all the stakeholders, putting at the center first and foremost the health objectives of the citizen, but also the 
healthcare professionals and staff who must be supported with appropriate motivational tools, coordination and 
identification of care priorities (Nuti et al., 2010; Murante et al., 2014; Vainieri et al, 2017). It is noticed (Vainieri 
et al., 2017) that healthcare entities should present a "reverse hierarchy" (or inverted pyramid) in which 
professionals take action on the delivery of quality and appropriate care whereas top management facilitates and 
orients their decisions and actions, supporting them with effective information strategies aimed to create value 
across the organization (Porter, 2010). In this context, the cost accounting approaches and specifically the 
micro-costing can lead to better decision-making processes. 
2.3 Micro-Cost Accounting Approach in Healthcare System  
The need of healthcare entities to rationalize the resources available and to give health professionals and 
managers the awareness of the costs related to organizational paths and alternative choices of intervention and 
treatments of patient diseases (Russo, 2011; Nuti et al., 2010) has boosted up researches on health cost 
accounting approaches. Many previous studies have already analyzed in depth the cost accounting systems in 
alternative care pathways, through the use of activity based and micro-costing methods (Chan and Ching, 1993; 
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Evans et al., 1997; Ross, 2004; Pizzini, 2006; Cinquini et al., 2007; Russo, 2011; Goldberg and Kosinski, 2011, 
Battaglia and Pedretti, 2012; Perazzo et al., 2017; Rejeb et al. 2017). The design of a micro-costing approach is 
related to the cost estimation of the health service for promoting organizational behaviors consistent with the 
production of the service and with the appropriate use of resources (Heerey et al., 2002; Tarricone, 2004, Frick, 
2009, Xu et al., 2014). The micro-costing method identifies different activities that the health entity performs, 
including the corresponding indirect costs (e.g. administrative and general costs) to estimate total cost of a 
procedure/organizational process (Cinquini et al., 2007). ABC method recognizes the relationship between costs, 
activities (called cost drivers) and products (e.g. exams, medical visit, intervention, ect) taking into account this 
relationship in the costing analysis (Frick, 2009). The adopted approach allows to recover the function of cost 
accounting system as a real support to decision-making processes through the enhancement of the link between 
cost information and management operations. The system improves the effectiveness in monitoring the processes 
of allocation and use of resources by which it’s possible to pursue simultaneously the clinical and economic 
needs (Schreyogg, 2008; Tan et al., 2008; Smith et al., 2010; Rejeb et al., 2017). As pointed out by Vainieri et al. 
(2017) better managerial practices like planning, organizing, coordinating, controlling, and also instruments like 
cost accounting, are significantly related to better clinical and financial performance (Bloom et al., 2009). 
As it has already mentioned before, the study is aimed, first of all, at verifying a possible correlation between the 
types of hospital ward (gastroenterology, general medicine and emergency medicine) and the determination of 
costs (fixed or variable) that generally result from the length of hospital stay, as well as clearly showing the 
causes of possible discrepancies. Secondly, the research pointed to determine if there is a statistical correlation 
between the variables that characterise the cases being analysed (e.g. comorbidity, level of bleeding, method of 
treatment) that would allow the identification of significant variations in average length of stay and hospital costs, 
depending on the hospital ward where the patient is admitted. Finally, the analysis of the results intends to 
evaluate how appropriate and “patient centred” is the level of organisation and allocation of the therapeutic and 
assistance processes. 
3. Research Design and Methods  
Using a shared protocol, the professionals and a team of researchers extracted and analyzed anonymous data 
from both regional and local databases including information on diagnosis and surgical procedures delivered to 
patients with peptic ulcer bleeding during the hospital stay. The data sources were: (i) the HDR database, which 
routinely collects data on hospital discharges, including referral source, discharge status, up to five discharge 
diagnoses (ICD- 9-CM), up to five hospital procedures (ICD-9-CM) and patient’s demographic data; (ii) the 
surgical registry (SR) database, which includes a description of the interventions, the date and the time of the 
interventions. The ICD-9-CM (International Classification of Diseases - Ninth Revision - Clinical Modification) 
was used to define the patient sample (Deyo et al., 1992; Quan et al., 2005; Ministero della Salute, 2016).  
The study sample consists of patients diagnosed with upper gastrointestinal bleeding – gastric or duodenal - who 
were hospitalised in the period 2015-2016 at the Molinette Hospital of the Azienda Ospedaliera Città della Salute 
e della Scienza di Torino. The discharged patients has been classified according to the type of their disease. 
Medical records of discharged patients with the above-mentioned disease were the main source of the data 
collected, analysed and re-elaborated for this research.  
The departments involved for this study are the following: Gastroenterology (S.C. Gastroenterologia U), General 
Medicine (S.C. Medicina Interna 1 U, S.C. Medicina Interna 2 U, S.C. Medicina Interna 3 U, S.C. Medicina 
Interna 4 U, S.C. Medicina Interna 5, S.C. Medicina Interna 6), Emergency Medicine (S.C. Medicina Urgenza, 
MECAU) and Liver Failure and Liver Transplantation (SSD Insufficienza Epatica e Trapianto Epatico).  
The ICD-9-CM coding system was applied to the Hospital Discharge Records (HDR) to subdivide the 
departments analysed, through the Quani programme (Ufficio Statistiche della S.C. Direzione Sanitaria). This 
originated 112 results. With the agreement of the Health Department, it was possible to analyse the medical 
records of 2015-2016 by inserting the identification code of each HDR/SDO into GesArcCC, the digital storage 
programme for medical records. 
From the resulting sample (n = 112), 22 patients were excluded for the following reasons: 
- patients without medical records in the GesArcCC system (n = 12); 
- patients hospitalised in the Liver Failure and Liver Transplantation Departments (n = 8), considered not 
relevant; 
- patients who voluntarily discharged themselves from the department (n = 1); 
- patients with perforated peptic ulcer (n = 1). 
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Table 1. Sample patients per department 
 2015 2016 Total
Gastroenterology 21 20 41 
General Medicine 15 14 29 
Emergency Medicine 9 11 20 
Total 45  45  90 
Source: author’s elaboration. 
 
Summing up, a sample of 90 patients (n = 45 for 2015; n = 45 for 2016) diagnosed with acute gastric or acute 
duodenal ulcer with bleeding were identified, divided into the hospital departments, as in Table 1. 
In this study, bleeding caused by 1) acute gastric ulcer (n = 46) and by 2) acute duodenal ulcer (n = 44) were 
considered homogenous because the relationship between the diagnostic-therapeutic procedure and the surgical 
procedure was the same in the two groups. Medical records of patients with bleeding peptic ulcer obtained from 
GesArcCC showed two macro-categories of variables: i) demographic and clinical features of the patients (e.g. 
sex; age; smoker; alcohol intake; corticosteroids consumption in the 30 days prior to admission; oral 
anticoagulant; antiplatelet therapy; previous episodes of bleeding peptic ulcer; comorbidity; ect.); ii) 
identification of health resources utilised and related costs during hospitalisation (e.g. number of days of hospital 
stay; number of Esophagogastroduodenoscopy (EGD) carried out during hospital stay; early diagnosis of EGD; 
previous interventional endoscopic therapy; previous endoscopic biopsy for detecting Helicobacter Pylori or for 
histological tests; number of blood bags transfused; type and screen tests required for transfusions; diagnostic 
and blood-chemistry tests prescribed; oral and infusion therapy administered during hospital stay). 
The cost analysis has been conducted using the micro-costing approach (Heerey et al., 2002; Tarricone, 2004, 
Frick, 2009, Xu et al., 2014), that is, based on each individual patient admitted. Previous studies (Schreyogg, 
2008; Smith et al., 2010; Tan et al., 2008; Rejeb et al., 2017) have demonstrated how micro-costing is especially 
useful for evaluating various healthcare activities/services. These are characterised by a wide range of 
interventions, combined with randomness, ex-ante, through the use of specific organisational standards, of care 
processes decided by the various healthcare providers operating along the “chain of care”. In particular, since 
micro-costing is a “bottom-up” approach to determining the cost of a healthcare activity or process, it is 
considered the most accurate method for measuring the cost of activities in healthcare services, seeing that all the 
items are identified and evaluated in the most detailed fashion, allowing for a generally objective analysis, 
especially if it is supported by health information technologies (HIT) that can gather multidimensional 
information on care processes in a ”capillary” way (Bardhan & Thouin, 2013). The chosen method is not 
adaptable in a unique way, but some phases used in this study and inspired by prior studies (Frick, 2009, Smith et 
al., 2010 e Rejeb et al., 2017) can be identified: i) formal description of the healthcare process and activity; ii) 
data collection; iii) application of a monetary value to resources utilised (costs and prices) and finally iv) 
determination of the total cost. 
After the identification of every single phase, it has detected what the cost drivers as variable with an economic 
impact on the departments involved:  
 Number of days of hospitalisation; 
 EGD and the interventional procedures/biopsies carried out;  
 Number of transfused blood bags and TS tests requested; 
 Diagnostic and blood-chemistry tests prescribed; 
 Oral and infusion therapy administered.  
The data for the average cost of a day of hospitalisation were obtained from the analytical accounting system 
data (financial and managerial accounting systems) in order to have a more systematic perspective, broken up 
into each item, as reported in table 2. 
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Table 2. Analytical hospitalisation costs (€/day) 
 Gastroenterology General Medicine Emergency Medicine 
Personnel/Staff 347.55 181.02 620.32 
Healthcare products 10.50 8.29 23.88 
Non-Healthcare products 0.76 0.69 1.03 
Services 4.04 3.14 29.46 
Amortisation 0.07 0.21 16.04 
Portion of general costs 173.28 83.60 145.34 
Total 536.4 276.95 836.07 
Source: author’s elaboration. 
 
The costs of EGD, transfusions, diagnostic and blood-chemistry tests were taken from the regional price list for 
services in force during the two-year period under analysis. The cost of the products used for interventional 
procedures (adrenaline, fibrin glue, hemoclips, etc.) to ensure hemostasis during EGDs, together with the cost of 
medicines administered either orally or through infusions, were obtained from the AMC system (accounting and 
control accounting system). Table 3 shows a summary of the macro-items of healthcare resources for the treated 
patients.  
 
Table 3. Macro-items of analysed healthcare resources in €s (2015 and 2016). Separators are in thousands 
 Gastroenterology General Medicine Emergency Medicine 
 2015 2016 2015 2016 2015 2016 
OGDS 1,535.2 1,984.7 1,584.8 1,560.3 794.7 1,798,2 
Blood transfused 1,329.9 1,089.0 522.9 574.5 687.0 411.9 
Diagnostic procedures 1,586.8 2,064.1 2,082.7 3,491.1 3,634.6 622.4 
Blood-chemistry 4,209.5 3,120.0 3,160.7 3,306.2 2,148.2 2,467.1 
Oral therapy 273.7 156.9 111.8 296.6 111.3 136.1 
Infusion therapy 409.2 291.6 1203.7 228.5 199.6 198.6 
Total 9,344.3 8,706.3 8,666.6 9,457.2 7,575.4 5,634.3 
Source: author’s elaboration. 
 
To describe the overall health of patients and to remove non-peptic ulcer related distorting factors from the study, 
the comorbidities found at the time of admission to the ward were considered. The Charlson Comorbidity Index 
(CHI), an indicator expressing the probability of survival in patients with multiple concomitant pathologies 
(Charlson, 1987, 1994) was calculated using these comorbidities for each patient in a readapted and validated 
version (Librero et al., 1999). Compared to the original version, rheumatic diseases and the acquired immune 
deficiency syndrome (AIDS) were included, which had not previously been considered by Charlson. An 
individual’s comorbidity score is based on the parameters measured by an episode and the scores that correspond 
to the measured parameters between episodes of an individual in the following way: chronic disease codes are 
evaluated in the corresponding episode only when they have been classified as a secondary diagnosis but are not 
the primary diagnosis. Acute disease codes are not counted in the episode in which they are recorded. Both types 
of codes are accumulated for each patient and counted in the comorbidity index of subsequent episodes (the first 
admission available at the hospital is used as an index episode, and no previous admission comorbidity has been 
added). Only one disease is counted in each of the groups (for example, a patient with cerebrovascular disease 
and neoplasms has a weight of 1 + 2 = 3, but a patient with two neoplasms has a weight of 2 and not 2 + 2). The 
weight of the original comorbidity index has been maintained for the different categories together with the 
calculation of the total score, which is reached by adding the weights of the different categories. Subsequently, 
from a more limited perspective compared to the disease treated, the Forrest classification (1974) was used, with 
the aimed at standardising, as much as possible, the type of bleeding peptic ulcers, stratifying the patients into 
high, intermediate and low risk of bleeding. This was done in order to verify whether the medical procedures that 
were performed and the related costs were consistent with the guidelines provided for each degree of severity of 
the peptic ulcer.  
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4. Results and Descriptive Analysis 
The main objective of the study, which gives rise to important considerations, is to determine whether the 
hospital department the patient with a bleeding peptic ulcer is allocated to makes it possible to predict the length 
of the stay and the total costs incurred, in the light of potential distorting factors which are not strictly related to 
the disease. The characteristics of the sample on which the statistical studies were carried out are summarised in 
table 4. 
 
Table 4. Characteristics of the sample – all the data is expressed as a numerical value, percentage and/or mean ± 
standard deviation  
Characteristics Gastroenterology General Medicine Emergency Medicine p-value 
Number 41 29 20  
Average age 61 ± 16.81 72 ± 18.59 70 ± 16.07 0.257 
Gender  
Male 
 
30 (73.2%) 
 
17 (58.6%) 
 
16 (80%) 
 
0.841 
Female 11 (26.8%) 12 (41.4%) 4 (20%)  
Smokers 
Not asked 
 
15 (36.6%) 
 
17 (58.6%) 
 
13 (65%) 
 
0.059 
Yes 15 (36.6%) 8 (27.6%) 5 (25%)  
No 11 (26.8%) 4 (13.8%) 2 (10%)  
Alcohol    0.176 
Not asked 23 (56.1%) 24 (82.8%) 15 (75%)  
Yes 10 (24.4%) 3 (10.3%) 3 (15%)  
No 8 (19.5%) 2 (6.9%) 2 (10%)  
Corticosteroids 5 (12.9%) 7 (24.1%) 2 (10%) 0.923 
Oral anti-coagulant therapy 13 (31.7%) 15 (51.7%) 10 (50%) 0.115 
Pre-existing peptic haemorrhage 14 (34.1%) 9 (31%) 8 (40%) 0.733 
Average days of stay 9 ± 4.83 14 ± 9.71 9 ± 3.70 0.902 
Average cost of stay 
Total average cost 
4,941.66 ± 2,591.47 
5,406.76 ± 2,733.38 
3,858.90 ± 2,689,62 
4,506.76 ± 3,336,06 
7,649.4 ± 3,095.81 
8,354.78 ± 3,635.31  
Source: author’s elaboration. 
 
The clinical variables reported were the subject of the ANOVA tests, which were carried out using the Stata 14.2 
software (Stata Corp., College Station, Texas, USA, 2013). Each result shows a p-value higher than 0.05 allows 
the comparability of the observed groups. Leaving aside the analysis of medical conditions and clinical results 
with reference to patients, it is essential to focus on the variables which are directly attributable to cost sources, 
examining the reasons for the inconsistencies found. The average number of days of hospitalisation is higher in 
the General Medicine department (14 days ± 9.7 DS), compared to the Gastroenterology department (9 days ± 
4.8 DS) and the Emergency Medicine department (9 days ± 3.7 DS). Nevertheless, the average cost recorded for 
the stay in General Medicine is the lowest (€ 3,858 ± 2,690 DS), increases for the Gastroenterology department 
(€ 4,941 ± 2,591 DS) and rises even further for the Emergency Medicine department (€ 7,649 ± 3,096 DS). This 
misalignment between the average period of hospitalisation and the average cost of hospitalisation is caused by 
the profound differences in the €/day cost attributed to each department, as already seen in the cost data in Table 
2. The cost per day for hospitalisation in Gastroenterology is € 536, in General Medicine it is € 277 and in 
Emergency Medicine it is € 836. It should be noted, however, that in the face of a considerable economic 
difference, there is a p-value calculated for total costs of 0.102, i.e. statistically the distribution of costs among 
the various departments is considerably homogeneous. Consequently, the different average length of stay is the 
compensatory factor, which is higher in the least expensive department but lower in the others. Moreover, the 
cost of hospitalisation is undoubtedly the most significant component of the total cost of managing patients 
suffering from bleeding peptic ulcers, accounting for 85.6% of the total cost of General Medicine (€ 3,858 out of 
€ 4,507), 91.4% of the total spent in Gastroenterology (€ 4,941 out of € 5,407) and as high as 91.5% of the total 
in Emergency Medicine (€ 7,649 out of € 8,354). A more detailed examination into the analytical breakdown of 
the hospitalisation costs shows that the item “personnel” accounts for the highest share: 65.3% in General 
Medicine, 64.8% in Gastroenterology and 74.2% in Emergency Medicine. As a fixed cost it is unchangeable, at 
least in the short-medium term. It is true that the size of the sample which was analysed is small compared to the 
ijbm.ccsenet.org International Journal of Business and Management Vol. 14, No. 2; 2019 
174 
 
data relating to the overall Italian healthcare expenditure. Finally, it is noted that there is no considerable 
statistical difference (p = 0.757) between the three departments regarding the costs of managing bleeding peptic 
ulcers, i.e. including OGDS, interventional procedures/biopsies, transfused blood bags, blood transfusion 
required, prescribed diagnostic and blood-chemistry tests and the oral and infusive therapy provided. The main 
reason is attributable to the lack of a real diagnostic-therapeutic strategy which is specific for each department. 
Numerous and multivariate linear regressions were carried out on the entire sample, as well as on the individual 
departments, in order to have a statistical degree of correlation between the variables that characterise the cases 
being analysed and to establish whether the treatment of bleeding ulcers leads to variations in terms of the length 
of hospitalisation and total cost depending on which department the patients are sent to STATA V.14,2 was used 
to conduct all the studies, taking a p value <0.05 to be significant. The robustness of the analyses carried out was 
verified. First of all, it is noted that the increase in the patients’ age corresponds to an increase in the number of 
days spent in hospital for the entire sample (p = 0.032; R-Squared = 0.0834), and the robustness of the model is 
8.34%. This is interesting if the number of cases examined is taken into consideration.  
The study continued with an assessment of the degree of correlation between comorbidity and hospitalisation 
costs and, subsequently, the one between the severity of the bleeding and the hospitalisation costs. The increase 
in the number of diseases present at the same time corresponds to an increase in the length of hospitalisation (p = 
0.002; R-Squared = 0.103). If it is applied to each department, this correlation remains for Gastroenterology (p = 
0.047; R-Squared = 0.097) and for Emergency Medicine (p = 0.037; R-Squared = 0.219), while General 
Medicine is the exception (p = 0.282; R-Squared = 0.046). Despite not having the same economic impact as the 
length of hospitalisation, it is still worth noting that even the diagnostic-therapeutic costs grow in relation to 
increases in comorbidity (p = 0.032; R-Squared = 0.005). As can be expected, the linear regression of 
comorbidity-total costs is also significant (p = 0.001; R-Squared = 0.114). Returning more specifically to the 
limited level of the treated disease, a linear regression was carried out on the total number of cases being studied 
between the three risk groups defined by Forrest (high, intermediate and low risk), assigned to the patients at the 
time of the EGD, and the number of days of hospitalisation. The overall result deviates from what had previously 
been expected, as there is no statistically significant correlation (p = 0.161). The increase in haemorrhagic 
severity does not correspond to a linear increase in the days spent on the ward. In order to interpret the reasons 
for this, regressions were also conducted into the situations of the individual hospitals. The only department to 
have reported an increase in the days of hospitalisation, proportionate to the risk defined by Forrest, was that of 
General Medicine (p = 0.035; R-Squared = 0.167). There is no linear correlation between the length of stay and 
the severity of bleeding in the Gastroenterology department (p = 0.262; R-Squared = 0.032) and in the 
Emergency Medicine department (p = 0.766; R-Squared = 0.005). In short, the type of bleeding has practically 
no impact on the length and cost of the three groups. This is supported by the fact that applying the same Forrest 
risk class there is no significant difference in the average number of days of hospitalisation, taking into account 
the relative costs differentiated for hospitalization: 6 days in Emergency Medicine, 7.1 days in Gastroenterology 
and 9.8 days in General Medicine. In other words, not detecting the severity of bleeding, together with to the fact 
that the panorama of clinical criticality is age-related, it is clear that the variable that most affects the cost of 
medical treatment is the level of comorbidity. 
 
Table 5. Breakdown by levels of comorbidity.  
Comorbidity Gastroenterology General Medicine EmergencyMedicine Breakdown % (n) per levels of comorbidity
0 15 (36.6%) 5 (17.2%) 4 (20%) 26.6% (n=24) 
 1 – 2 18 (43.9%) 12 (41.4%) 9 (45%) 43.3% (n=39) 
≥ 3 8 (19.5%) 12 (41.4%) 7 (35%) 30.1% (n=27) 
Source: author’s elaboration. 
 
On the basis of the above, an analysis of the data in Table 5 risks leading to the conclusion that the economically 
logical allocation of the therapeutic-assistance process should be made by levels of comorbidity, that is, to 
allocate to the most onerous wards the patients with none or few comorbidities, since the likelihood that they will 
stay in a less severe department is high. This statement is incorrect for at least two reasons: 
- from an economic-statistical point of view, the significant correlation between the level of comorbidity and 
the extent of hospitalisation is verified only retrospectively, i.e. with the specific departmental allocations made 
in the two-year period under analysis;  
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- patients with numerous pathologies treated in a non-specialised ward would generate a lengthening of the 
stay, thus eliminating any economic advantage.  
Furthermore, from a clinical point of view, as has been previously on several occasions, in addition to the 
efficiency required in the allocation of the resources, it is also necessary to take into consideration therapeutic 
effectiveness, professional appropriateness and the results of the process. 
5. Conclusions and Further Research Development 
Compared to the analysis carried out by Quirk et al. (1997) and Pardo et al. (2002), during this study the 
definition of costs was made in analytic terms on each individual patient so as to make it possible to define the 
micro-costing average of each cost taken into consideration in the best possible way. Both the Pardo et al. (2002) 
study and ours also take into consideration the costs of the diagnosis. The analysis shows results which are 
consistent with findings from previous studies, thus it is possible to make a generalisation regarding all the 
health authorities whose organisation and the allocation of patients are carried out in the same way. In this 
scenario, the implementation of strategies aimed at effectively containing hospital health costs, thus reducing the 
length of time stable patients remain in hospital, becomes a decisive factor (Saiani & Brugnolli, 2014). Even 
though there is also a fairly wide range of potential corrective measures available, there are three main areas 
(Gabrielli et al., 2007). First of all, it is essential to reduce the length of stay in hospital, maintaining the quantity 
and quality of the diagnostic-therapeutic procedures, by means of a variety of joint efforts:  
− The use of hours of the day that have been considered previously to carry out the diagnostic procedures, 
such as the evenings or holidays;  
− The gradual replacement of the step-by-step method with the immediate request for potentially useful 
assessments;  
− Accurate detection, prior to admittance to the hospital ward, of the seriousness of the case in order to send 
the patients to the suitable department;  
− Reduction of cases where, due to the lack of clear and strict guidelines, doctors are resorted to basing the 
clinical picture solely on their experience.  
Secondly, the high number of procedures, which often turn out to be superfluous, which are implemented to 
make a diagnosis, has a huge impact on the total costs. The elimination of some routine tests which are not 
specific or, in some circumstances, are simply aimed at avoiding liability, known as defensive medicine (Roiati, 
2012). Finally, the last factor which has been the subject of lengthy discussion, is that of analytical conformity 
which establishes the daily cost for a hospital stay. It is currently deemed to be a variable which cannot be 
modified, as it is composed of fixed costs. However, long-lasting results may be obtained by re-configuring the 
organisational processes, limiting waste and organically assessing the key performances which have already been 
discussed in depth. A prolonged hospital stay is neither economically viable nor positive for the health of the 
patient. In fact, there are frequent cases of extremely long waiting times for a hospital bed, thus increasing the 
risk of infection and cognitive impairment, especially in elderly patients. It is precisely for all these reasons that 
it is essential to avoid the procedures for the discharge from hospital which are clinically and / or socially 
complex, delayed or early discharges or those that have not been sufficiently prepared, as the latter can lead to 
numerous cases where the patient is then re-admitted into hospital or has to return several times. The hope is that 
in future organisation will be based on the intensity of the treatment in order to distribute the personnel costs in a 
homogeneous way on the basis of the levels of comorbidity or gravity (Nicosia & Lagostena, 2008; Gualano et 
al., 2016). However, as previous studies has highlighted (Smaldone and Vainieri, 2016; Nuti et al., 2017; 
Murante et al., 2017), it is not sufficient to put in place performance measurement systems and tools, these 
should be disclosed with effective communication strategies throughout the whole organization fostering the 
cognitive effect of performance measurement and giving feedback information to support the decision-making 
processes both of physicians and management professionals. Further research could be performed with the aim 
to consider the adoption of multi-level and multi-dimensional evidence based performance measurement systems, 
strictly correlated with soft management styles able to promote the sharing of knowledge and leverage learning 
processes to promote organizational and management innovation. Finally, an appropriate understanding and 
interpretation of the economic performance data often requires additional qualitative data collection more 
patient-centred, for example, indicators able to shed light on patients’ expectations, experiences and health 
behaviour. 
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